Perioperative prophylaxis for percutaneous nephrolithotomy: Randomized study concerning the drug and dosage

Journal of Endourology

Volumn 26, Issue 11, 2012, Pages 1431-1436

  Seyrek, Mahir ^a   Binbay, Murat ^a   Yuruk, Emrah ^a   Akman, Tolga ^a   Aslan, Rahmi ^a   Yazici, Ozgur ^a   Berberoglu, Yalcin ^a   Muslumanoglu, Ahmet Y ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEPHROSTOMY TUBE; PERCUTANEOUS NEPHROLITHOTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; URINE CULTURE; UROSEPSIS;

ADOLESCENT; ADULT; AGED; AMPICILLIN; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CEFUROXIME; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; NEPHROSTOMY, PERCUTANEOUS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; SULBACTAM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 84869061450     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2012.0242     Document Type: Article

References (22)

1. Michel MS, Trojan L, Rassweiler JJ. Complications in percutaneous nephrolithotomy. Eur Urol 2007;51:899-906. (Pubitemid 46281422)
2. Segura JW, Preminger GM, Assimos DG, et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol 1994;151:1648-1651. (Pubitemid 24151330)
3. O'Keeffe NK, Mortimer AJ, Sambrook PA, Rao PN. Severe sepsis following percutaneous or endoscopic procedures for urinary tract Stones. Br J Urol 1993;72:277-283. (Pubitemid 23280591)
4. Grabe M, Bjerklund-Johensen TE, Botto H, et al. Members of the European Association of Urology (EAU) Guidelines Office. Guidelines on Urological Infections. In: EAU Guidelines, edition presented at the 25th EAU Annual Congress, Barcelona 2010.ISBN 978-90-79754-70-0.
5. .Wolf JS Jr, Bennett CJ, Dmochowski RR, et al. Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008;179:1379-1390.
6. .Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: A systematic review. Eur Urol 2008;54:1270-1286.
7. .ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
8. .Turk C, Knoll T, Petrik A, et al. Members of the European Association of Urology (EAU) Guidelines Office. Guidelines on Urolithiasis. In: EAU Guidelines, edition presented at the 25th EAU Annual Congress, Barcelona 2010. ISBN 978-90- 79754-70-0.
9. Bag S, Kumar S, Taneja N, et al. One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: A prospective controlled study. Urology 2011;77:45-49.
10. Yamamoto S, Shima H, Matsumoto T. Controversies in perioperative management and antimicrobial prophylaxis in urologic surgery. Int J Urol 2008;15:467-471. (Pubitemid 351713196)
11. Chen L, Xu QQ, Li JX, et al. Systemic inflammatory response syndrome after percutaneous nephrolithotomy: An assessment of risk factors. Int J Urol 2008;15:1025-1028.
12. Draga RO, Kok ET, Sorel MR, et al. Percutaneous nephrolithotomy: Factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol 2009;23:921-927.
13. Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: A prospective controlled study. BJU Int 2006;98:1075-1079. (Pubitemid 44536462)
14. Charton M, Vallancien G, Veillon B, Brisset JM. Urinary tract infection in percutaneous surgery for renal calculi. J Urol 1986;135:15-17. (Pubitemid 16187139)
15. Darenkov AF, Derevianko II, Martov AG, et al. [The prevention of infectious-inflammatory complications in the postoperative period in percutaneous surgical interventions in patients with urolithiasis.] (Rus) Urol Nefrol (Mosk) 1994;2:24-26.
16. Dogan HS, Sahin A, Cetinkaya Y, et al. Antibiotic prophylaxis in percutaneous nephrolithotomy: Prospective study in 81 patients. J Endourol 2002;16:649-653. (Pubitemid 35340760)
17. Fourcade RO. Antibiotic prophylaxis with cefotaxime in endoscopic extraction of upper urinary tract stones: A randomized study. The Cefotaxime Cooperative Group. J Antimicrob Chemother 1990;26(suppl A):77-83. (Pubitemid 20281726)
18. Shigeta M, Hayashi M, Igawa M. A clinical study of upper urinary tract calculi treated with extracorporeal shock wave lithotripsy: Association with bacteriuria before treatment. Urol Int 1995;54:214-216.
19. Kumar S, Bag S, Ganesamoni R, et al. Risk factors for urosepsis following percutaneous nephrolithotomy: Role of 1 week of nitrofurantoin in reducing the risk of urosepsis. Urol Res 2012;40:79-86.
20. Negrete-Pulido O, Gutierrez-Aceves J. Management of infectious complications in percutaneous nephrolithotomy. J Endourol 2009;23:1757-1762.
21. Korets R, Graversen JA, Kates M, et al. Post-percutaneous nephrolithotomy systemic inflammatory response: A prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol 2011;186:1899-1903.
22. Gonen M, Turan H, Ozturk B, Ozkardes H. Factors affecting fever following percutaneous nephrolithotomy: A prospective clinical study. J Endourol 2008;22:2135-2138.